These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2114437)

  • 1. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
    J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
    Lee FY; Tsai YT; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lai KH; Lo KJ
    J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D; Gimson A; Hayes PC; Williams R
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
    Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
    J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
    Romero G; Kravetz D; Argonz J; Bildozola M; Suarez A; Terg R
    J Hepatol; 2000 Mar; 32(3):419-25. PubMed ID: 10735611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of triglycyl-lysine vasopressin plus nitroglycerin in patients with HBsAg-positive cirrhosis.
    Lin HC; Tsai YT; Chang TT; Lee FY; Wang SS; Lay CS; Lee SD; Lo KJ
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():224-7. PubMed ID: 2519061
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
    Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
    Garcia-Tsao G; Groszmann RJ
    Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].
    Valla D; Lee SS; Moreau R; Hadengue A; Sayegh R; Lebrec D
    Gastroenterol Clin Biol; 1985 Dec; 9(12):877-80. PubMed ID: 3830801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study.
    Therapondos G; Stanley AJ; Hayes PC
    J Gastroenterol Hepatol; 2004 Jan; 19(1):73-7. PubMed ID: 14675246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
    Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K
    Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
    Rector WG; Hossack KF
    J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic responses to 1.25 and 2 mg of terlipressin intravenously in man.
    Freeman JG; Barton JR; Record CO
    Aliment Pharmacol Ther; 1988 Aug; 2(4):361-7. PubMed ID: 2979260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.